For citations:
Kolbin A.S., Kurylev A.A., Mishinova S.A., Balykina Yu.E., Proskurin M.A. Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2020;(1):23-34. (In Russ.) https://doi.org/10.37489/2588-0519-2020-1-23-33